Module Overview

Haematology 2

This module will focus on the aetiology and pathophysiology of haematological malignancies. Current and advancing practice in the diagnosis, monitoring and treatment of a variety of myeloid and lymphoid diseases will be discussed.

The CORU Standards of Proficiency covered in this module include Domain 5 Professional Knowledge and Skills; P30 & P31

Module Code

BIOL 4223

ECTS Credits


*Curricular information is subject to change

Lecture Programme;

  • Review of the pathophysiology and current/emerging laboratory diagnostics and treatments of a selection of haematological malignancies;
  • Haematopoiesis; Detailed investigation into proliferation, differentiation, maturation and regulation of haematopoietic stem cells in the bone marrow;
  • Haematological Malignancies; Myelodysplastic Neoplasms, Acute Leukaemia Chronic Leukaemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Plasma cell disorders, Myeloproliferative Neoplasms;  
  • Therapies; Chemotherapy; Radiotherapy; Stem cell transplantation; CAR-T cell therapy; Antibody therapy; Pathway Inhibitors;

Practical and Workshop Programme;

  • The principle and application of laboratory tests which aid in the diagnosis, classification and monitoring of haematological malignancies; blood film and bone marrow microscopy, immunophenotyping, chromosomal abnormalities and molecular analysis;
  • Evidence based critical skills workshops.

Lectures (18 hr), tutorials (4 hr), case study based practical classes (5 hr) / workshops (13 hr)

Module Content & Assessment
Assessment Breakdown %
Formal Examination60
Other Assessment(s)40